Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ISOLAGEN INC | 200,000 | reported | 01 Mar 2016 | tx 2+202,000 |
| OptiNose, Inc. | 141,726 | reported | 16 Mar 2022 | tx 20+658,135−8,655 |
| Syndax Pharmaceuticals Inc | 140,429 | reported | 09 Feb 2026 | tx 24+791,295−12,366 |
| NUPATHE INC. | 0 | reported | 21 Feb 2014 | tx 13+205,366−348,171 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2026 | SALE | Syndax Pharmaceuticals Inc | 1,177 | 18.99 USD | |
| 09 Feb 2026 | SALE | Syndax Pharmaceuticals Inc | 3,410 | 21.03 USD | |
| 30 Jan 2026 | OTHER | Syndax Pharmaceuticals Inc | 1,219 | 8.48 USD | |
| 06 Feb 2026 | SALE | Syndax Pharmaceuticals Inc | 2,082 | 20.62 USD | |
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 30,750 | 0.00 USD | |
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 21,500 | 0.00 USD | |
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 118,000 | 20.43 USD | deriv |
| 01 Dec 2025 | GIFT | Syndax Pharmaceuticals Inc | 1,224 | 0.00 USD | |
| 31 Jul 2025 | OTHER | Syndax Pharmaceuticals Inc | 1,226 | 8.43 USD | |
| 16 Jul 2025 | SALE | Syndax Pharmaceuticals Inc | 1,296 | 9.29 USD | |
| 19 May 2025 | PURCHASE | Syndax Pharmaceuticals Inc | 3,000 | — | |
| 10 Feb 2025 | SALE | Syndax Pharmaceuticals Inc | 3,777 | 15.50 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 18,500 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 23,400 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 110,500 | 14.65 USD | deriv |
| 14 Jun 2024 | PURCHASE | Syndax Pharmaceuticals Inc | 1,250 | 20.03 USD | first after silence |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 11,700 | 0.00 USD | |
| 31 Jan 2024 | OTHER | Syndax Pharmaceuticals Inc | 1,183 | 17.42 USD | |
| 31 Jul 2023 | OTHER | Syndax Pharmaceuticals Inc | 862 | 18.12 USD | |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 35,000 | 0.00 USD | |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 70,000 | 22.28 USD | deriv |
| 13 Jun 2023 | SALE | Syndax Pharmaceuticals Inc | 577 | 22.31 USD | |
| 02 Feb 2023 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 110,000 | 28.55 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 3,205 | 0.00 USD | |
| 13 Jun 2022 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 230,000 | 15.60 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 14 Jun 2024.